These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
504 related articles for article (PubMed ID: 6253269)
1. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone. Marcus R; Orner FB; Brickman AS Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269 [TBL] [Abstract][Full Text] [Related]
2. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8. Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids and 1,25-dihydroxyvitamin D3 regulate parathyroid hormone stimulation of adenosine 3',5'-monophosphate-dependent protein kinase in rat osteosarcoma cells. Titus L; Rubin JE; Lorang MT; Catherwood BD Endocrinology; 1988 Sep; 123(3):1526-34. PubMed ID: 2456915 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats. Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502 [TBL] [Abstract][Full Text] [Related]
5. Forskolin increases 1,25-dihydroxyvitamin D3 production by rat renal slices in vitro. Armbrecht HJ; Forte LR; Wongsurawat N; Zenser TV; Davis BB Endocrinology; 1984 Feb; 114(2):644-9. PubMed ID: 6317364 [TBL] [Abstract][Full Text] [Related]
6. Effect of PTH and 1,25(OH)2D3 on renal 25(OH)D3 metabolism, adenylate cyclase, and protein kinase. Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB Am J Physiol; 1984 Jan; 246(1 Pt 1):E102-7. PubMed ID: 6320659 [TBL] [Abstract][Full Text] [Related]
7. The effect of vitamin D on bone in vivo. Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118 [TBL] [Abstract][Full Text] [Related]
8. Interaction between 24R,25-dihydroxycholecalciferol and 1,25-dihydroxycholecalciferol on 45Ca release from bone in vitro. Mahgoub A Calcif Tissue Int; 1981; 33(6):663-6. PubMed ID: 6799176 [TBL] [Abstract][Full Text] [Related]
9. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line. Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D metabolites do not alter parathyroid hormone secretion acutely. Magliola L; Anast CS; Forte LR Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783 [TBL] [Abstract][Full Text] [Related]
11. The effects of 1,25-dihydroxycholecalciferol on embryonic bone in vitro: a biochemical and histological study. Herrmann-Erlee MP; Gaillard PJ Calcif Tissue Res; 1978 May; 25(2):111-8. PubMed ID: 208719 [TBL] [Abstract][Full Text] [Related]
12. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group. Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555 [TBL] [Abstract][Full Text] [Related]
13. Lack of a direct effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by normal bovine parathyroid glands. Golden P; Greenwalt A; Martin K; Bellorin-Font E; Mazey R; Klahr S; Slatopolsky E Endocrinology; 1980 Aug; 107(2):602-7. PubMed ID: 6893023 [TBL] [Abstract][Full Text] [Related]
14. Interaction of the parathyroid and 1,25-dihydroxyvitamin D3 in the control of renal 25-hydroxyvitamin D3 metabolism. Omdahl JL J Biol Chem; 1978 Dec; 253(23):8474-8. PubMed ID: 711762 [TBL] [Abstract][Full Text] [Related]
15. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3. Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells. Klaus G; von Eichel B; May T; Hügel U; Mayer H; Ritz E; Mehls O Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093 [TBL] [Abstract][Full Text] [Related]
17. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I. Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788 [TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin. Henry HL Endocrinology; 1985 Feb; 116(2):503-10. PubMed ID: 2981664 [TBL] [Abstract][Full Text] [Related]
19. Developmental changes in the responsiveness of rat kidney to vitamin D metabolites. Sömjen D; Weisman Y; Berger E; Earon Y; Kaye AM; Binderman I Endocrinology; 1986 Jan; 118(1):354-9. PubMed ID: 3000745 [TBL] [Abstract][Full Text] [Related]
20. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]